BRIDGEBIO ONCOLOGY THERAPEUT

Historical 13F Holders

Symbol
BBOT
CUSIP
107924102
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 107924102 since 12/18/2024, largest first.

Filer % of Class Filed
Helix Holdings II LLC 13D/A
22.6% 8/13/2025
Event 8/11/2025
Bihua Chen 13D/A
22.3% 7/6/2026
Event 7/1/2026
BridgeBio Pharma LLC 13D
17.5% 8/18/2025
Event 8/11/2025
James E. Flynn 13G
6.2% 8/18/2025
Event 8/11/2025
BC Global Opportunities IX LP 13G
5.5% 9/3/2025
Event 9/4/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Citadel Advisors LLC 13G/A
3.2% 11/14/2025
Event 9/30/2025
Adage Capital Management, L.P. 13G/A
1.9% 11/13/2025
Event 9/30/2025
Price T Rowe Associates Inc /MD/ 13G 1.1% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 140 k $576 k
2026 Q2 65 59.1 M $451 M
2026 Q1 68 57.5 M $514 M
2025 Q4 52 57.9 M $725 M
2025 Q3 42 56.8 M $658 M